This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Benzinga·06/15/2026 13:15:24

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

BTIG analyst Sam Eiber initiated coverage on ICU Medical Inc (NASDAQ:ICUI) with a Buy rating and announced a price target of $170. ICU Medical shares closed at $142.20 on Friday. See how other analysts view this stock.
HC Wainwright & Co. analyst Yi Chen initiated coverage on Biodesix Inc (NASDAQ:BDSX) with a Buy rating and announced a price target of $26. Biodesix shares closed at $15.06 on Friday. See how other analysts view this stock.
Needham analyst Charles Shi initiated coverage on Ceva Inc (NASDAQ:CEVA) with a Buy rating and announced a price target of $55. CEVA shares closed at $46.03 on Friday. See how other analysts view this stock.
Evercore ISI Group analyst Benjamin Rubin initiated coverage on Lincoln International Inc (NYSE:LCLN) with an In-Line rating and announced a price target of $25. Lincoln International shares closed at $24.84 on Friday. See how other analysts view this stock.
JP Morgan analyst Tomohiko Sano initiated coverage on ESCO Technologies Inc (NYSE:ESE) with an Overweight rating and announced a price target of $420. ESCO Technologies shares closed at $313.74 on Friday. See how other analysts view this stock.

Considering buying ICUI stock? Here’s what analysts think:

Photo via Shutterstock

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English